Data by Sector within Total Market
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Sector |
(Millions) |
(Millions) |
(Millions) |
Number |
Basic Materials Sector |
$ 3,710,816 |
$ 277,316 |
$ 172,145 |
1,872,950 |
Capital Goods Sector |
$ 3,012,729 |
$ 1,350,320 |
$ 114,530 |
2,426,117 |
Conglomerates Sector |
$ 309,345 |
$ 121,648 |
$ 9,933 |
281,790 |
Consumer Discretionary Sector |
$ 6,320,385 |
$ 1,656,309 |
$ 107,470 |
3,637,879 |
Consumer Non Cyclical Sector |
$ 2,626,425 |
$ 1,114,785 |
$ 99,784 |
1,797,356 |
Energy Sector |
$ 3,838,775 |
$ 3,535,747 |
$ 305,039 |
477,228 |
Financial Sector |
$ 12,901,236 |
- |
$ 719,639 |
5,962,567 |
Healthcare Sector |
$ 6,537,219 |
- |
$ 82,349 |
3,477,727 |
Services Sector |
$ 7,127,690 |
- |
$ 210,443 |
9,647,439 |
Technology Sector |
$ 22,326,856 |
$ 331,823 |
$ 506,360 |
6,898,195 |
Transportation Sector |
$ 2,907,029 |
$ 669,940 |
$ 39,324 |
1,616,221 |
Utilities Sector |
- |
$ 1,159,504 |
$ 130,163 |
639,396 |
Retail Sector |
$ 4,962,261 |
$ 4,986,854 |
$ 137,254 |
11,060,650 |
Total Market |
- |
$ 3,704,760 |
$ 2,634,431 |
49,795,515 |
Recent News from Total Market |
Financing Agreement
HOUSTON Crescent Energy Company (NYSE: CRGY) announced today that its subsidiary, Crescent Energy Finance LLC, intends to offer $700 million in Senior Notes due 2032 to eligible purchasers. The Notes will be guaranteed on a senior basis, subject to market conditions. Despite a net increase in borrowings of -11.39% in the fourth quarter of 2023, C...
|
|
Management Announcement
1. Article for : InflaRx, a pioneering biopharmaceutical company focused on developing anti-inflammatory therapeutics targeting the complement system, is set to make a significant announcement concerning its upcoming development plans for a potential game-changer, INF904. Alongside this, the company will release its much-awaited financial and operatin...
|
|
Clinical Study
Evaxion Biotech A/S, a leading clinical-stage TechBio company specializing in AI-Immunology powered vaccines, recently held a Research and Development (RandD) Day at its H?rsholm facilities in Denmark. The event aimed to showcase the groundbreaking capabilities of Evaxion's AI-Immunology platform, which holds immense promise in revolutionizing vaccine dev...
|
|
Product Service News
In a groundbreaking move, Howard Hughes Corporation has recently joined forces with Discovery Land Company to introduce a new premier residential tower within the vibrant Ward Village community. Spearheaded by renowned architectural firm Robert A.M. Stern Architects, this collaboration aims to create a truly exceptional living experience that will revolut...
|
|
Product Service News
Gilat Unveils Cloud and 5G NTN Evolution Strategy for SkyEdge IVIn a recent announcement, Gilat Satellite Networks Ltd revealed its new cloud and 5G NTN evolution strategy for its SkyEdge IV platform. The company aims to adopt a phased approach to ensure continuous advancement in alignment with evolving technology and maturing standards.Under this strateg...
|
|
Product Service News
Fluke Revolutionizes Utility-Scale Solar Testing with PVA-1500 Series I-V Curve TracerEverett, Wash. - Fluke Corp, a global leader in test and measurement instruments and a subsidiary of Fortive Corporation NYSE: FTV, has introduced the PVA-1500 Series I-V curve tracer. This state-of-the-art tool aims to enhance the capabilities of utility-scale solar tec...
|
|
Product Service News
Enveric Biosciences Signs Term Sheets for Out-Licensing Neuroplastogenic Compounds and Unveils Promising Drug Candidates for Mental Health DisordersEnveric Biosciences (NASDAQ: ENVB), a biotechnology company focused on developing innovative small-molecule therapeutics for depression, anxiety, and addiction disorders, has made significant advancements in i...
|
|
Product Service News
Paramount Gold Nevada's proposal for the high-grade Grassy Mountain gold and silver mine has recently garnered attention. The Bureau of Land Management (BLM) filing a Notice of Intent in the federal registry has sparked discussions about the potential environmental impact and economic benefits of the project. In light of this development, it is crucial to...
|
|
Business Update
In a recent announcement, Scholar Rock, a leading late-stage biopharmaceutical company, shared their financial results and corporate updates for the full year 2023. The company is dedicated to developing innovative treatments for various severe diseases, with a particular focus on spinal muscular atrophy (SMA), cardiometabolic disorders, and conditions wh...
|
|
Clinical Study
Axsome Therapeutics, a renowned biopharmaceutical company focused on advancing cutting-edge therapies to address central nervous system disorders, is set to revolutionize the treatment landscape for Major Depressive Disorder (MDD). The company has recently announced the commencement of the PARADIGM Phase 3 trial for their investigational drug, solriamfeto...
|
|
|
|
|
|